Recent evidence has demonstrated that simultaneous activation of PPAR isoforms and inhibition of cyclooxygenase-2 (COX-2) may be a good approach to treat inflammatory diseases and cancer [25,26]. The gene discussed is PTGS2; the disease is cancer.